Improving the lives of Canadian children and youth with rare diseases
Improving the lives of Canadian children and youth with rare diseases
Improving the lives of Canadian children and youth with rare diseases
Improving the lives of Canadian children and youth with rare diseases
Improving the lives of Canadian children and youth with rare diseases
Improving the lives of Canadian children and youth with rare diseases
New study on Serious and life-threatening events associated with non-medical (recreational) cannabis use in Canadian children and youth

In September 2018, the Canadian Paediatric Surveillance Program (CPSP) began a new study on serious and life-threatening events associated with non-medical (recreational) cannabis use in Canadian children and youth. For more information and to report a case, refer to the case definition and protocol.

One-time survey surveillance grant from the CPSP

The Canadian Paediatric Surveillance Program (CPSP) is offering CPS residents/subspecialty resident a chance to apply for a $3,000 in-kind surveillance grant to conduct a one-time survey through the CPSP. Application deadline: Friday September 7, 2018.

ADR Tips

Find out timely tips on adverse drug reactions reported to the CPSP and Health Canada.

CPSP studies

The CPSP facilitates studies in a variety of fields, such as infectious diseases, congenital and genetic diseases, injury prevention and mental health. View lists of current studies and concluded studies.

Annual Results

Results pertaining to studies and surveys are published annually. Click here for CPSP Results from 1999.

Electronic Reporting Option

Sign up for monthly electronic reporting today. The process is quick and simple – a hyperlink is sent to you each month and no log-in and password are required.

Sign Up Now

The Canadian Paediatric Surveillance Program

The Canadian Paediatric Surveillance Program (CPSP) contributes to the improvement of the health of children and youth in Canada by national surveillance and research into childhood disorders that are high in disability, morbidity and economic costs to society, despite their low frequency.  Read More.